APA (7th ed.) Citation

Shan, Y., Ding, B., Ji, F., Lin, H., Shi, W., Wang, E., . . . Shen, Y. (2026). T‐cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first‐in‐human dose‐escalation trial for platinum‐resistant advanced ovarian cancer. Cancer (0008543X), 132(3), 1. https://doi.org/10.1002/cncr.70279

Chicago Style (17th ed.) Citation

Shan, Yiyang, Bo Ding, Feng Ji, Hao Lin, Weiwei Shi, Enxiu Wang, Chen Wang, and Yang Shen. "T‐cell Receptor–like Chimeric Antigen Receptor T Cells Targeting Mesothelin: A First‐in‐human Dose‐escalation Trial for Platinum‐resistant Advanced Ovarian Cancer." Cancer (0008543X) 132, no. 3 (2026): 1. https://doi.org/10.1002/cncr.70279.

MLA (9th ed.) Citation

Shan, Yiyang, et al. "T‐cell Receptor–like Chimeric Antigen Receptor T Cells Targeting Mesothelin: A First‐in‐human Dose‐escalation Trial for Platinum‐resistant Advanced Ovarian Cancer." Cancer (0008543X), vol. 132, no. 3, 2026, p. 1, https://doi.org/10.1002/cncr.70279.